Comments

Turnstone Biologics Stock Price, Quotes and Forecasts

Q: What sector and industry does Turnstone Biologics (TSBX) operate in?

Turnstone Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

TSBXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.3527

0.026.14%

At close: -

$0.3500

-0.00270-0.77%

After Hours: Jun 27, 7:59 PM EDT

Turnstone Biologics (TSBX) announced it will be merged with XOMA Royalty (XOMA) on Friday, June 27, 2025

Turnstone Biologics (TSBX) Forecast

News Earnings Turnstone Biologics (TSBX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Turnstone Biologics Stock Price, Quotes and Forecasts | NASDAQ:TSBX | Benzinga

Explore Turnstone Biologics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for TSBX.

Open	$0.37
Close	$0.35
Volume / Avg.	5.14M / 259.80K
Day Range	$0.35 - $0.38
52 Wk Range	0.29 - 3.00
Market Cap	$8.10M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	3.74%
Days to Cover	1

Recent News

Crude Oil Gains Over 1%; Alibaba Posts Weak Revenue

Avi Kapoor

Nasdaq Jumps Over 2%; Walmart Earnings Top Views

Avi Kapoor

Turnstone Biologics Shifts Focus To 'High Unmet Medical Need' Cancers, Shares Initial Data From Colorectal Cancer Cell Therapy Study

Turnstone Biologics stock drops after Phase 1 STARLING trial data reveals mixed results for TIDAL-01 in metastatic colorectal cancer, with a 25% response rate.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.37
Close	$0.35
Volume / Avg.	5.14M / 259.80K
Day Range	$0.35 - $0.38
52 Wk Range	0.29 - 3.00
Market Cap	$8.10M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	3.74%
Days to Cover	1

About Turnstone Biologics Corp

Sector

Health Care

Industry

Biotechnology

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicin...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Turnstone Biologics (TSBX) stock?

You can purchase shares of Turnstone Biologics (NASDAQ:TSBX) through any online brokerage.

View our list of the best stock brokerages

Who are Turnstone Biologics (TSBX) competitors?

Other companies in Turnstone Biologics’s space includes: Synaptogenix (NASDAQ:SNPX), Intensity Therapeutics (NASDAQ:INTS), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Genprex (NASDAQ:GNPX) and TransCode Therapeutics (NASDAQ:RNAZ).

What is the forecast, or price target, for Turnstone Biologics (TSBX) stock?

Turnstone Biologics has a consensus price target of $4.75.

What is the current price for Turnstone Biologics (TSBX)?

The stock price for Turnstone Biologics (NASDAQ: TSBX) is $0.35 last updated June 27, 2025 at 7:59 PM EDT.

Does Turnstone Biologics (TSBX) pay a dividend?

There are no upcoming dividends for Turnstone Biologics.

When is Turnstone Biologics (NASDAQ:TSBX) reporting earnings?

Turnstone Biologics’s Q2 earnings are confirmed for Wednesday, August 13, 2025.

Is Turnstone Biologics (TSBX) going to split?

There is no upcoming split for Turnstone Biologics.

What sector and industry does Turnstone Biologics (TSBX) operate in?

Turnstone Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.